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INTRODUCTION
After the finding by our laboratories of a strong association between the A1 allele of the O 2 dopamine receptor gene and alcoholism I, several groups were unable to replicate the observation/ 9. We have suggested two possible reasonsfirst, inadequate screening of controls for alcohol, drug, and tobacco abuse; and, second, sampling errors in terms of characterization of alcoholics for chronicity and severity of the disease.
Here we review the evidence that the O 2 dopamine receptor gene (DR0 2) is associated not only with alcoholism but also with a group of impulsive-addictive-eompulsive disorders including polysubstance abuse, smoking, attention deficit hyperactivity disorder, obesity, and Tourette' s syndrome that we have termed 'reward deficiency svndrome' 10.
In brain tissue obtained from patients carrying the AI, B l , and intronv-exon 7 haplotypes of the OR0 2 gene dopamine 02 receptor densities are low 1o, 25,30. Similarly, OR0 2 densities have been found lower in alcohol-preferring rodents than in alcohol-non-preferring animals 31-B . Moreover, O 2 receptor agonists reduce, and 02 receptor agonists increase, alcohol intake in alcohol-preferring rats H .
LINKAGE VERSUS ASSOCIATION
Although several studies excluded linkage of the OR0 2 gene with alcoholism'': 10,23,26, one group using affected sib-pair analyses found linkage with both heavy drinking and alcoholism/". Further support for association comes from separate studies. In one, the A! al1ele was present in 69% of severe alcoholics! compared with 20% of controls. In another, the gene frequency of the A! al1ele of the OR0 2 gene in unclassified alcoholics was 0.27 compared with 0.07 in well-characterized non-alcoholic controls, a 3.85-fold risk in these probands 23 . Moreover, a meta-analysis on al1 published exant studies related to alcoholism showed an odds ratio of 2.18 with a p-value of 10-7 indicating strong correlation of the ORD2 gene with this disease 35, 36 . Variants of the OR02 gene have been correlated with increased . k f' I h I· 1 1720 22 24 rIS 0 severe a co 0 Ism' , . , crack/cocaine dcpendence 28,29,38, carbohydrate bingeing 39, obcsity''", attention deficit hyperactivity disorder 41, Tourcttc' s syndrome"! ,42, pathological gambling4\ and smoking 44 46 . Table 1 summarizes data for drug and alcohol seeking behaviour: in al1 reports chemical dependent subjects were exclusion criteria for controls-! , and such efforts are essential because alcoholism per se is not the true phenotype associated with DRD 2 gene polymorphisms lO • 23.+1 • Moreover, to calculate the sensitivity of genotyping we took data from studies where the probands were characterized for chronicity or severity of disease ( Table 2 ). The positive predictive value (PV+) of a test is the percentage of positive results that are true positives when the test is applied to a population containing both healthy and diseased individuals-t.Wtth the Taql Al genotype, P.\f+ was 0.744 or 74%; in other words, positive predictive value was high; but PV -was only 0.548 or 54.8%. We would expect better negative predictive value in studies where individuals with related impulsive-addictive-compulsive the environment or other gene defects, and data from twin studies indicate that genes influence up to 60% of the vulnerability to severe substance abuse'". If these two findings are taken together, the DRD 2 variants could represent one of the most important singlegene determinants of susceptibility to severe substance abuse. The consensus among researchers is that vulnerability to drug and alcohol seeking behaviour is polygenic in nature, the DRD2 genotype being only one of the factors49-52.59-61.
We have used Bayes'53 theorem as a mathematical method to evaluate the predictive value of the AI allele of the DRD 2 gene in impulsive-addictive-compulsive .disorders. Bayes' theorem is widely used in medicine to predict the likelihood that a particular event (defect) will result in an another event (disease)-here, for example, that possession of the AI allele of DRD 2 will cause abnormal drug and alcohol seeking behaviour ( Table 2) .
When a screening test is evaluated, sensitivity is the probability that the test will be positive in a person with the disease in question; and specificity is the probability that the test will be negative in a person who does not have the disease. For Bayes' theorem we used the following formula:
To calculate the specificity, we used well-characterized controls, screened for alcohol, drug, and tobacco use in some samples (Table 1) . No previou~study has used rigid behaviours are excluded from the control groups. Pooled data on patients with these disorders point to a strong positive correlation with the DRD 2 gene variant (Yates X 2=68.38, ij=1, P<10- 7 ) .
DNA testing to predict high risk
Using logistic regression modelling, we found especially with cocaine dependent probands that the prevalence of the variants of the DRD 2 gene increases with three factorsparental alcoholism; intake of potent drugs; and early deviant bchaviour/". Of eight individuals with the three risk factors, seven had the AI allele. A similar pattern was seen in obesity, the risk factors for prevalence of the A1 allele including parental obesity, adolescent or adult-onset of obesity, and carbohydrate bingeing: of 13 obese individuals with these three risk factors 11 had the Al allele 38 . We also find that co-morbid substance abuse with obesity yielded a D 2A] allelic prevalence of 82%55.
In summary, there is now convincing cumulative evidence that certain variants of the DRD 2 are associated with impulsive-addictive-compulsive disorders. Moreover, in the alcohol-naive sons of alcoholic fathers, presence of the A] allele correlates with a neurophysiological featuredelayed latency of the P300 wave-that predicts drug and alcohol seeking behaviour 56 ,57. The association was also present in a neuropsychiatric population58. DRD 2 seems to be a major gene in these disorders, with the larger role played b) a combination of other genes (DRD 4 ) and environmental factorst", Lately Crabbe et al. 59 , working with animal models of alcohol and drug seeking behaviour, found evidence that several responses to alcohol (sensitivity to ataxia, tolerance to hypothermic and ataxia effects, preference drinking, and conditioned place preference) are influenced by loci in the middle portion of chromosome 9. In fact, four of the five traits showed their highest association with the same marker, CyplA I, at 9: 31. This strongly suggests that a single locus accounts for all these associations. Consumption of methamphetamine (in saccharin), methamphetamine-stimulated activity, and haloperidol-induced catalepsy also map to this region, and morphine-induced Straub tail maps nearby. Moreover, the ethanol-preference and haloperidol-catalepsy associations with markers near DRD 2 have been verified in F2 mice with PCR genotyping. The potential importance of this synthetic approach is a cluster of ethanol, morphine, and cocaine responses mapping to chromosome 9. Finally, Crabbe et al. point out that, in the mouse, the DRD 2 gene maps to chromosome 9. These findings in animals support our proposal that variants of the O 2 dopamine receptor gene are important common genetic determinants of addictive behaviours.
Although several studies strongly support a genetic aetiology for severe alcoholismv", others point to the importance of environmental factors such as peer pressure, family, and socioeconomics'i'.
Since the DRD 2 gene was found to be associated with various 'reward deficiency syndrome' behaviours (Table 1) , we agree with Neiswanger' s23 suggestion that alleles of the DRD 2 gene associate with aberrant behavioural phenotype. An example of polygenic inheritance has been observed with attention deficit hyperactivity disorder (ADHD). Comings and associates'v found three dopaminergic genes-DRD 2, dopamine p-hydroxylase, and the dopamine transporter-to associate individually with ADHD in patients originally diagnosed with Tourette's syndrome: those who inherited all three of the alleles in question had the highest ADHD scores, well into the clinical range, and those who inherited none of the three alleles had the lowest ADHD scores, well into the normal range. The results for conduct disorder and oppositional defiant disorder were particularly important because these conditions were so widely regarded as due entirely to environmental factors. There is further evidence of common genetic factors. Gittleman 63 found a correlation between ADD and adult drug abuse and Comings et al. 62 ,64 showed an intimate relationship between Tourette' s syndrome and ADD: 50-80% of persons with Tourette's syndrome had ADD.
REWARD DEFICIENCY SYNDROME
The concept of a 'reward deficiency syndrome' unites addictive, impulsive, and compulsive behaviours and may explain how simple genetic anomalies give rise to complex aberrant behaviour. What are the possible therapeutic implications? Ntshimura'v has reported that bromocriptine shortens the latency of the N200 wave in persons with long latency. Such N200 wave abnormalities occur in 'reward deficiency syndrome', and if bromocriptine or other O 2 agonists can stabilize or shorten wave latency, they could have clinical value. In a double-blind study bromocriptine or a placebo was administered to alcoholics with either the AI (All Al and AllA2 genotypes) or only the A 2 (A 21 A 2 ) genotype allele of the DRD2 gene. The greatest improvement in craving and anxiety occurred in the bromocriptinetreated AI alcoholics and attrition was highest in the placebo group AI alcoholics. These findings raise the possibility of selection in treatment of alcoholics. .
One important obstacle to treatment or rehabilitation in substance use disorders is denial, and we believe that a positive result of the 'reward deficiency syndrome' concept will be its aid in countering this reaction: as many as one out of every two individuals seeking treatment for a 'reward deficiency syndrome' disorder carry the AI allele. For prevention and early identification the test has a predictive value of only 74%. A time will come, however, when we have identified all the gene variants and we shall have a stronger DNA test for reward deficiency syndrome.
